Quantification of Hepatitis C Virus (HCV) RNA in a Multicenter Study: Implications for Management of HCV Genotype 1-Infected Patients
Authors:
- 1 September 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (9) , 2931-2936
Abstract
Assessment of the viral load in hepatitis C virus (HCV) genotype 1-infected patients is critical before, during, and after antiviral therapy. In patients achieving a rapid virological response at week 4 of treatment, the viral load at the baseline is considered a predictive criterion of a sustained virological response 24 weeks after the discontinuation of treatment. A ≥2-log10drop in the viral load at week 12 of treatment (early virological response) triggers the continuation of therapy. We organized a multicenter study (MS) for diagnostic laboratories involved in the quantification of HCV RNA. Commercial assays, including two based on real-time reverse transcription-PCR (TaqMan system), and in-house methods, were used by the 61 participants. The overall reproducibility of the commercial quantitative nucleic acid amplification techniques (qNAT) was acceptable. As the intermethod variability among commercial qNAT for HCV RNA was still present, the manufacturers of these test kits should join efforts to harmonize the means of quantification of HCV RNA. This study also shows that caution should be exercised when the baseline viral load is evaluated and when the 2-log10reduction after 12 weeks of therapy is interpreted. Finally, this MS confirms the higher sensitivity of the commercial qNAT based on the TaqMan system, making them the elective assays for the monitoring of therapy.Keywords
This publication has 16 references indexed in Scilit:
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- How to use virological tools for optimal management of chronic hepatitis CLiver International, 2009
- Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trialHepatology, 2008
- Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trialHepatology, 2007
- Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction–based methodHepatology, 2007
- Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in ItalyJournal of Clinical Virology, 2004
- Inter‐laboratory comparison of HCV‐RNA assay results: Implications for multi‐centre researchJournal of Medical Virology, 2002
- External Quality Assessment Program for Qualitative and Quantitative Detection of Hepatitis C Virus RNA in Diagnostic VirologyJournal of Clinical Microbiology, 2002
- Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNAVox Sanguinis, 1999
- Procedures for Detecting Outlying Observations in SamplesTechnometrics, 1969